We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Siemens Enters Dx Agreement with Pfizer

News   Dec 16, 2013

 
Siemens Enters Dx Agreement with Pfizer
 
 
Advertisement
 

RELATED ARTICLES

Acoustically Actuated Microscopic Device Developed

News

Researchers at EPFL have developed remote-controlled, mechanical microdevices that, when inserted into human tissue, can manipulate the fluid that surrounds them, collect cells or release drugs. This breakthrough offers numerous potential applications in the biomedical field, from diagnostics to therapy.

READ MORE

Rapid Test for COVID-19 Shows Improved Sensitivity

News

A CRISPR-based test developed at MIT and the Broad Institute can detect nearly as many cases as the standard COVID-19 diagnostic.

READ MORE

CRISPR-Based Method Enables Ultrasensitive Visual Detection of SARS-CoV-2

News

In March, UConn researchers began to develop a new, low-cost, CRISPR-based diagnostic platform to detect infectious diseases such as SARS-CoV-2. Today, the method is one step closer to being a cutting-edge diagnostics technology for rapid detection of infectious diseases.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE